MEDICAL RESEARCH AND YNHH
Yale experts make strides in Multiple Sclerosis research

Scientists at Yale School of Medicine have investigated the connection between inflammation and autoimmune diseases, particularly Multiple Sclerosis, and its impact on disease progression and quality of life.

Concerns and questions follow Yale New Haven Health System’s proposal to acquire three Conn. hospitals

Yale New Haven Health’s recent plan to acquire three new hospitals has sparked conversations and concerns over the impact of hospital consolidation on policy and economy.

Yale receives $10 million to study COVID-19 pathogenesis and its long-term effects

Yale researchers at the School of Medicine studying the pathogenic mechanisms and long-term effects of COVID-19 receive HHMI grant to further support their collaborative studies.

Yale researchers map gene regulation in tissue using novel sequencing technology

Yale researchers are the first to analyze gene regulation patterns in tissue after developing novel spatial epigenetics mapping technology.

Yale alumna becomes youngest female unicorn CEO

April Koh ’16 and Adam Checkroud GRD ’18 have created an entrepreneurial unicorn, or private company valued at above $1 billion, that aims to improve the delivery of mental healthcare services.

Yale and National Brain Tumor Society launch DNA Damage Response consortium

Yale professor Ranjit Bindra’s lab will launch the DNA Damage Response Consortium with the National Brain Tumor Society in order to further cutting-edge treatment for brain cancer.

A space for healers in need of healing

In a two-day writing workshop, resident physicians reflected on and derived meaning from the challenging world of medicine.

Yale study identifies potential target genes to develop therapeutic treatments for heart defect

A team of Yale researchers, led by Jui Dave and Daniel Greif, has identified potential therapeutic targets for combating the effects of supravalvular aortic stenosis.

Yale researchers develop model system for the study of Alzheimer’s

Researchers in the department of genetics at the Yale School of Medicine have developed a technique that allows them to construct 3D brain organoids to better study Alzheimer’s disease.

Yale New Haven Health System purchases three hospitals in Connecticut, transitions them to nonprofits

In a Feb. 10 press release, the Yale New Haven Health System announced an expansion of its hospital network as part of a larger agreement with the Prospect Medical Holdings Incorporation.

Social media post leads Yale scientist to long COVID discovery

Akiko Iwasaki’s active Twitter use might have led her to the treatment for long COVID after finding a Facebook poll made by individuals with the condition.